These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30744931)

  • 21. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
    de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
    Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease.
    Drakontaeidi A; Pontiki E
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease.
    Pathak C; Kabra UD
    Bioorg Chem; 2024 Mar; 144():107152. PubMed ID: 38290187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.
    Penumala M; Zinka RB; Shaik JB; Mallepalli SKR; Vadde R; Amooru DG
    BMC Complement Altern Med; 2018 Mar; 18(1):77. PubMed ID: 29499679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
    Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
    Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.
    Chioua M; Buzzi E; Moraleda I; Iriepa I; Maj M; Wnorowski A; Giovannini C; Tramarin A; Portali F; Ismaili L; López-Alvarado P; Bolognesi ML; Jóźwiak K; Menéndez JC; Marco-Contelles J; Bartolini M
    Eur J Med Chem; 2018 Jul; 155():839-846. PubMed ID: 29958119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
    Milelli A; De Simone A; Ticchi N; Chen HH; Betari N; Andrisano V; Tumiatti V
    Curr Med Chem; 2017; 24(32):3522-3546. PubMed ID: 28294041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease.
    Ismaili L; do Carmo Carreiras M
    Curr Top Med Chem; 2017; 17(31):3319-3327. PubMed ID: 29332584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Zhou Y; He Y; Teng X; Mi J; Yang J; Wei R; Liu W; Ma Q; Tan Z; Sang Z
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2231661. PubMed ID: 37414563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.
    Najafi Z; Saeedi M; Mahdavi M; Sabourian R; Khanavi M; Tehrani MB; Moghadam FH; Edraki N; Karimpor-Razkenari E; Sharifzadeh M; Foroumadi A; Shafiee A; Akbarzadeh T
    Bioorg Chem; 2016 Aug; 67():84-94. PubMed ID: 27289559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
    Xu M; Peng Y; Zhu L; Wang S; Ji J; Rakesh KP
    Eur J Med Chem; 2019 Oct; 180():656-672. PubMed ID: 31352246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
    Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
    Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
    Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
    Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New flavonoid -
    Estrada-Valencia M; Herrera-Arozamena C; Pérez C; Viña D; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Laurini E; Pricl S; Rodríguez-Franco MI
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):712-727. PubMed ID: 31852270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment.
    Dakhlaoui I; Bernard PJ; Pietrzak D; Simakov A; Maj M; Refouvelet B; Béduneau A; Cornu R; Jozwiak K; Chabchoub F; Iriepa I; Martin H; Marco-Contelles J; Ismaili L
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S; Kettle C; Morton DW
    Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug.
    Chand K; Rajeshwari ; Candeias E; Cardoso SM; Chaves S; Santos MA
    Metallomics; 2018 Oct; 10(10):1460-1475. PubMed ID: 30183790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's Disease, the "One-Molecule, One-Target" Paradigm, and the Multitarget Directed Ligand Approach.
    Oset-Gasque MJ; Marco-Contelles J
    ACS Chem Neurosci; 2018 Mar; 9(3):401-403. PubMed ID: 29465220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.